Pathogenesis of Endometriosis: New Insights into Prospective Therapies
Endometriosis is a female reproductive disorder characterized by growth of uterine cells and tissue in distant sites. Around 2–10% of women experience this condition during reproductive age, 35–50% of whom encounter fertility issues or pain. To date, there are no established methods for its early di...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/10c299029b4c40ab8cf388fdc48de384 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:10c299029b4c40ab8cf388fdc48de384 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:10c299029b4c40ab8cf388fdc48de3842021-11-11T17:09:38ZPathogenesis of Endometriosis: New Insights into Prospective Therapies10.3390/ijms2221117001422-00671661-6596https://doaj.org/article/10c299029b4c40ab8cf388fdc48de3842021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11700https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Endometriosis is a female reproductive disorder characterized by growth of uterine cells and tissue in distant sites. Around 2–10% of women experience this condition during reproductive age, 35–50% of whom encounter fertility issues or pain. To date, there are no established methods for its early diagnosis and treatment, other than surgical procedures and scans. It is difficult to identify the disease at its onset, unless symptoms such as infertility and/or pain are present. Determining the mechanisms involved in its pathogenesis is vital, not only to pave the way for early identification, but also for disease management and development of less invasive but successful treatment strategies. Endometriosis is characterized by cell proliferation, propagation, evasion of immunosurveillance, and invasive metastasis. This review reports the underlying mechanisms that are individually or collectively responsible for disease establishment and evolution. Treatment of endometriosis mainly involves hormone therapies, which may be undesirable or have their own repercussions. It is therefore important to devise alternative strategies that are both effective and cause fewer side effects. Use of phytochemicals may be one of them. This review focuses on pharmacological inhibitors that can be therapeutically investigated in terms of their effects on signaling pathways and/or mechanisms involved in the pathogenesis of endometriosis.Radhika KapoorChristina Anna StratopoulouMarie-Madeleine DolmansMDPI AGarticleendometriosispathogenesisinflammationestrogen signalingapoptosisepithelial–mesenchymal transitionBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11700, p 11700 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
endometriosis pathogenesis inflammation estrogen signaling apoptosis epithelial–mesenchymal transition Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
endometriosis pathogenesis inflammation estrogen signaling apoptosis epithelial–mesenchymal transition Biology (General) QH301-705.5 Chemistry QD1-999 Radhika Kapoor Christina Anna Stratopoulou Marie-Madeleine Dolmans Pathogenesis of Endometriosis: New Insights into Prospective Therapies |
description |
Endometriosis is a female reproductive disorder characterized by growth of uterine cells and tissue in distant sites. Around 2–10% of women experience this condition during reproductive age, 35–50% of whom encounter fertility issues or pain. To date, there are no established methods for its early diagnosis and treatment, other than surgical procedures and scans. It is difficult to identify the disease at its onset, unless symptoms such as infertility and/or pain are present. Determining the mechanisms involved in its pathogenesis is vital, not only to pave the way for early identification, but also for disease management and development of less invasive but successful treatment strategies. Endometriosis is characterized by cell proliferation, propagation, evasion of immunosurveillance, and invasive metastasis. This review reports the underlying mechanisms that are individually or collectively responsible for disease establishment and evolution. Treatment of endometriosis mainly involves hormone therapies, which may be undesirable or have their own repercussions. It is therefore important to devise alternative strategies that are both effective and cause fewer side effects. Use of phytochemicals may be one of them. This review focuses on pharmacological inhibitors that can be therapeutically investigated in terms of their effects on signaling pathways and/or mechanisms involved in the pathogenesis of endometriosis. |
format |
article |
author |
Radhika Kapoor Christina Anna Stratopoulou Marie-Madeleine Dolmans |
author_facet |
Radhika Kapoor Christina Anna Stratopoulou Marie-Madeleine Dolmans |
author_sort |
Radhika Kapoor |
title |
Pathogenesis of Endometriosis: New Insights into Prospective Therapies |
title_short |
Pathogenesis of Endometriosis: New Insights into Prospective Therapies |
title_full |
Pathogenesis of Endometriosis: New Insights into Prospective Therapies |
title_fullStr |
Pathogenesis of Endometriosis: New Insights into Prospective Therapies |
title_full_unstemmed |
Pathogenesis of Endometriosis: New Insights into Prospective Therapies |
title_sort |
pathogenesis of endometriosis: new insights into prospective therapies |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/10c299029b4c40ab8cf388fdc48de384 |
work_keys_str_mv |
AT radhikakapoor pathogenesisofendometriosisnewinsightsintoprospectivetherapies AT christinaannastratopoulou pathogenesisofendometriosisnewinsightsintoprospectivetherapies AT mariemadeleinedolmans pathogenesisofendometriosisnewinsightsintoprospectivetherapies |
_version_ |
1718432161775747072 |